Balyasny Asset Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,600
Closed -$271K 3432
2025
Q2
$271K Buy
+5,600
New +$286K ﹤0.01% 2505
2023
Q1
Sell
-260,000
Closed -$12.6M 3114
2022
Q4
$12.6M Sell
260,000
-880,000
-77% -$38.6M 0.03% 641
2022
Q3
$43.3M Buy
+1,140,000
New +$50.8M 0.13% 184
2021
Q2
Sell
-50,000
Closed -$4.21M 2319
2021
Q1
$4.21M Buy
+50,000
New +$2.4M 0.02% 756
2019
Q4
Sell
-100,000
Closed -$4.63M 1466
2019
Q3
$4.63M Buy
+100,000
New +$4.31M 0.03% 562
2019
Q2
Sell
-270,000
Closed -$12M 1709
2019
Q1
$12M Buy
+270,000
New +$11.6M 0.08% 348
2018
Q4
Sell
-400,000
Closed -$17.7M 1733
2018
Q3
$17.7M Buy
400,000
+175,000
+78% +$7.48M 0.08% 336
2018
Q2
$9M Sell
225,000
-300,000
-57% -$11.8M 0.04% 518
2018
Q1
$21M Buy
525,000
+399,400
+318% +$16.6M 0.09% 314
2017
Q4
$5.4M Buy
+125,600
New +$5.79M 0.02% 833
2017
Q3
Sell
-1,537,500
Closed -$73.7M 2082
2017
Q2
$73.7M Buy
+1,537,500
New +$73.5M 0.3% 70

Other funds holding SNY

Balyasny Asset Management's SNY Position: Q1 2026 in Review

Balyasny Asset Management opened a new position in Sanofi (SNY) in Q1 2026: 833,780 shares worth $40.2M. The stake represents 0.05% of the portfolio and ranks #414 among its holdings. This is a return to the name: Balyasny Asset Management previously reported a position in SNY as recently as Q3 2025.

Balyasny Asset Management first reported a position in SNY in Q4 2015 and has held it in 27 quarters since. The position peaked at $120M in Q2 2017. 743 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Balyasny Asset Management held 833,780 shares of Sanofi worth $40.2M as of Q1 2026.
  • Sanofi was a new Balyasny Asset Management position in Q1 2026.
  • Sanofi made up 0.05% of Balyasny Asset Management's portfolio in Q1 2026, its #414 holding.
  • Balyasny Asset Management first reported a position in Sanofi in Q4 2015 and has held it in 27 quarters since.
  • Balyasny Asset Management's Sanofi position peaked at $120M in Q2 2017.
  • 743 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.